Herceptin
Boehringer puts afatinib head-to-head with Herceptin
December 10, 2010Research and Development BIBW 2992, Boehringer Ingelheim, Herceptin, Roche, Tovok, afatinib, breast cancer
Boehringer Ingelheim has set up a showdown between one of its pipeline oncology products and Roche’s Herceptin. It has started …
NICE recommends Herceptin for gastric cancer, blocks high dose Glivec
November 24, 2010Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer
NICE has recommended Roche’s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …
New Herceptin data sways NICE
September 30, 2010Sales and Marketing Herceptin, NICE, Roche
NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …
Roche submits new version of Herceptin for US approval
July 7, 2010Research and Development, Sales and Marketing Herceptin, Roche, breast cancer
Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …
NICE set to block Herceptin for gastric cancer
July 6, 2010Sales and Marketing Herceptin, NICE, Roche, gastric cancer
NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …
Roche expands Herceptin franchise
February 8, 2010Sales and Marketing Herceptin, Roche, gastric cancer, stomach cancer
Roche’s blockbuster breast cancer treatment Herceptin has been launched in the UK as a treatment for stomach cancer. It is …
Roche invests in production of new Herceptin formulation
January 25, 2010Manufacturing and Production, Research and Development Herceptin, Roche
Roche will spend 190 million Swiss francs ($183m) to put production capacity in place for a new self-administered formulation of …
Herceptin scientist wins Janssen award for biomedical research
September 8, 2009Research and Development Herceptin, Janssen
Johnson & Johnson has honoured the career achievements of Axel Ullrich by awarding him with the 2009 Dr Paul Janssen …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
